What is Quest Patent's earnings per share (EPS)?

Quest Patent (QPRC) reported diluted earnings per share of $-1.59 for fiscal year 2026. This represents a -245.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Quest Patent Financials

QPRC

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows Quest Patent (QPRC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 23 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI QPRC FY2025 2026-05-15

Quest Patent Research remains a financing-dependent enterprise, with episodic earnings bursts failing to stabilize a heavily burdened balance sheet.

In FY2025, financing became the operating engine: the company raised $14.6M while operations used -$5.9M of cash, an inversion of what a self-funding business looks like. With another -$9.0M leaving through investing, cash still ended thin at $193K, showing new money was absorbed by cash needs rather than rebuilding liquidity.

The balance sheet is liability-heavy: FY2025 closed with $27.6M of liabilities against $10.4M of assets, so creditors effectively finance the whole capital structure. Short-term pressure is especially acute because current assets were only $207K versus $27.4M of current liabilities, leaving little room for timing delays or operating misses.

Results are highly episodic rather than steadily compounding: FY2023 produced $3.6M of net income, but FY2024 swung to -$2.5M, which suggests the business does not yet run on a smooth recurring earnings base. Because operating cash flow moved from $1.9M positive in FY2023 to -$390K in FY2024, that profit burst did not translate into durable internal funding.

Financial Health Signals

Financial Profile 0/100

Based on FY2026 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Quest Patent's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Liquidity

Quest Patent's current ratio of 0.01 is below the typical benchmark, resulting in a score of 0/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Piotroski F-Score Weak

3/9

Quest Patent passes 3 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass.

Earnings Quality Low Quality

-0.70x

For every $1 of reported earnings, Quest Patent generates $-0.70 in operating cash flow (-$5.9M OCF vs $8.5M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk

-11.0x

Quest Patent earns $-11.0 in operating income for every $1 of interest expense (-$7.7M vs $700K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

N/A

EBITDA

N/A

Net Income

$8.5M

YoY+443.6%

Quest Patent reported $8.5M in net income in fiscal year 2026. This represents an increase of 443.6% from the prior year.

EPS (Diluted)

$-1.59

YoY-245.7%

Quest Patent earned $-1.59 per diluted share (EPS) in fiscal year 2026. This represents a decrease of 245.7% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$193K

YoY-60.0%

5Y CAGR-4.9%

10Y CAGR-5.3%

Quest Patent held $193K in cash against $0 in long-term debt as of fiscal year 2026.

Dividends Per Share

N/A

Shares Outstanding

YoY+0.0%

Quest Patent had 5M shares outstanding in fiscal year 2026. This represents an increase of 0.0% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

N/A

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

QPRC Income Statement

Metric	FY26	FY24	FY23	FY22	FY21	FY20
Revenue	N/A	$2.8M-78.7%	$13.2M+2815.0%	$451K-78.0%	$2.0M-62.6%	$5.5M
Cost of Revenue	$4.1M+248.6%	$1.2M-78.1%	$5.3M+6154.1%	$85K	N/A	N/A
Gross Profit	-$4.1M-528.1%	$951K-84.8%	$6.2M+4134.5%	$148K-79.9%	$735K	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$3.6M+29.3%	$2.8M+2.1%	$2.7M+38.4%	$2.0M-48.6%	$3.8M+154.2%	$1.5M
Operating Income	-$7.7M-316.4%	-$1.8M-152.7%	$3.5M+291.4%	-$1.8M+41.2%	-$3.1M-333.2%	-$719K
Interest Expense	$700K+488.6%	$119K-50.5%	$240K+190.2%	$83K+128.4%	-$292K-136.3%	$804K
Income Tax	N/A	$100K+233.3%	$30K+2494.3%	-$1K-169.4%	$2K-97.2%	$65K
Net Income	$8.5M+443.6%	-$2.5M-167.7%	$3.6M+584.3%	-$754K+81.9%	-$4.2M-216.6%	-$1.3M
EPS (Diluted)	$-1.59-245.7%	$-0.46-207.0%	$0.43+407.1%	$-0.14+82.7%	$-0.81	$0.00

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	N/A	N/A	N/A	N/A	N/A	$0-100.0%	$900K+5.9%	$850K
Cost of Revenue	$1.7M	N/A	$0	$0	$0+100.0%	-$1K-100.3%	$382K+20.1%	$318K
Gross Profit	-$1.7M	N/A	N/A	-$5K-37.0%	-$3K-449.6%	$1K-99.6%	$248K-46.4%	$463K
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$1.1M	N/A	$1.0M+2.3%	$989K+51.1%	$654K+2.3%	$639K-16.3%	$764K-6.4%	$816K
Operating Income	-$2.8M	N/A	-$1.0M-1.8%	-$994K-51.1%	-$658K+25.6%	-$884K-71.3%	-$516K-46.1%	-$353K
Interest Expense	$181K	N/A	$178K+3.0%	$173K+2.6%	$168K+142.4%	-$397K-368.3%	$148K-35.6%	$230K
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	-$5K-104.8%	$105K
Net Income	-$2.9M	N/A	-$1.2M-7.9%	-$1.1M-37.9%	-$826K+17.5%	-$1.0M-69.4%	-$591K-32.3%	-$447K
EPS (Diluted)	$-0.55	N/A	$-0.23-9.5%	$-0.21-40.0%	$-0.15	N/A	$-0.11-37.5%	$-0.08

QPRC Balance Sheet

Metric	FY26	FY24	FY23	FY22	FY21	FY20
Total Assets	$10.4M+194.8%	$3.5M-51.4%	$7.3M+493.4%	$1.2M+50.3%	$817K-76.6%	$3.5M
Current Assets	$207K-58.7%	$502K-86.1%	$3.6M+3660.2%	$96K-65.4%	$277K-78.5%	$1.3M
Cash & Equivalents	$193K-60.0%	$482K-14.5%	$563K+521.9%	$91K-65.8%	$265K+6.8%	$248K
Inventory	N/A	N/A	N/A	N/A	$2K-97.2%	$65K
Accounts Receivable	$8K0.0%	$8K-99.7%	$3.0M	N/A	N/A	$1.0M
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$27.6M+125.7%	$12.2M-9.4%	$13.5M+38.1%	$9.8M+12.0%	$8.7M-15.4%	$10.3M
Current Liabilities	$27.4M+127.8%	$12.0M-9.6%	$13.3M+38.9%	$9.6M+14.1%	$8.4M-11.5%	$9.5M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$17.2M-97.6%	-$8.7M-39.5%	-$6.2M+27.2%	-$8.6M-8.0%	-$7.9M-15.9%	-$6.8M
Retained Earnings	-$34.9M-32.2%	-$26.4M-10.3%	-$23.9M+8.7%	-$26.2M-3.0%	-$25.4M-19.5%	-$21.3M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$10.3M-1.2%	$10.4M-5.2%	$11.0M-5.8%	$11.7M+291.6%	$3.0M-15.7%	$3.5M-18.0%	$4.3M-0.1%	$4.3M
Current Assets	$655K+216.3%	$207K+6.6%	$194K-30.3%	$279K+238.1%	$82K-83.6%	$502K-55.7%	$1.1M+15.8%	$979K
Cash & Equivalents	$620K+221.8%	$193K+10.0%	$175K-31.2%	$255K+432.5%	$48K-90.1%	$482K+252.4%	$137K0.0%	$137K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$10K+16.3%	$8K0.0%	$8K0.0%	$8K0.0%	$8K0.0%	$8K-99.1%	$908K+19.8%	$758K
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$30.4M+10.2%	$27.6M+20.6%	$22.9M+2.5%	$22.4M+78.7%	$12.5M+2.2%	$12.2M+1.9%	$12.0M+5.1%	$11.4M
Current Liabilities	$30.2M+10.3%	$27.4M+20.8%	$22.7M+2.5%	$22.1M+80.0%	$12.3M+2.2%	$12.0M+1.9%	$11.8M+5.2%	$11.2M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$20.1M-17.1%	-$17.2M-44.5%	-$11.9M-11.5%	-$10.7M-12.0%	-$9.5M-9.5%	-$8.7M-13.0%	-$7.7M-8.3%	-$7.1M
Retained Earnings	-$37.8M-8.4%	-$34.9M-17.9%	-$29.6M-4.3%	-$28.3M-4.2%	-$27.2M-3.1%	-$26.4M-3.9%	-$25.4M-2.4%	-$24.8M

QPRC Cash Flow Statement

Metric	FY26	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$5.9M-1416.3%	-$390K-120.2%	$1.9M+311.2%	-$914K-1740.4%	-$50K+79.8%	-$246K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$9.0M	N/A	-$3.3M-121.7%	-$1.5M-30.6%	-$1.1M-1110.5%	-$95K
Financing Cash Flow	$14.6M+4636.2%	$309K-83.5%	$1.9M-16.5%	$2.2M+84.3%	$1.2M+2241.2%	$52K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	-$2.2M+51.6%	-$4.4M-800.3%	-$494K+9.1%	-$543K-25.1%	-$434K-180.6%	-$155K+69.0%	-$500K-156.0%	$893K
Capital Expenditures	N/A	N/A	$0	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	-$494K	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	$0	$0	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	$2.6M-42.2%	$4.5M+977.2%	$414K	N/A	N/A	$500K0.0%	$500K+132.7%	-$1.5M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

QPRC Financial Ratios

Metric	FY26	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	34.0%-13.5pp	47.5%+14.8pp	32.7%-3.2pp	35.9%	N/A
Operating Margin	N/A	-66.1%-92.7pp	26.7%+432.7pp	-406.1%-254.2pp	-151.9%-138.8pp	-13.1%
Net Margin	N/A	-88.4%-116.2pp	27.8%+194.8pp	-167.0%+35.7pp	-202.7%-178.8pp	-23.9%
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	81.4%+151.2pp	-69.8%-119.9pp	50.1%+111.5pp	-61.4%+447.4pp	-508.8%-471.1pp	-37.6%
Current Ratio	0.01-0.0	0.04-0.2	0.27+0.3	0.01-0.0	0.03-0.1	0.14
Debt-to-Equity	-1.61-0.2	-1.41+0.8	-2.17-1.0	-1.14-0.0	-1.10+0.4	-1.51
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	27.6%-26.9pp	54.5%
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	-57.3%-15.8pp	-41.5%
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	-65.7%-13.1pp	-52.6%
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	-28.5%	N/A	-11.2%-1.4pp	-9.8%+18.0pp	-27.7%+0.6pp	-28.3%-14.6pp	-13.7%-3.3pp	-10.3%
Current Ratio	0.02+0.0	0.010.0	0.010.0	0.010.0	0.01-0.0	0.04-0.1	0.100.0	0.09
Debt-to-Equity	-1.51+0.1	-1.61+0.3	-1.93+0.2	-2.10-0.8	-1.31+0.1	-1.41+0.2	-1.56+0.0	-1.61
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: Shareholder equity is negative (-$17.2M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.01), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Wildpack Beverag WLDPF

$811K

International ILST

$839K

Caro Holdings CAHO

$13.9M

Elvictor Group, Inc ELVG

$4.2M

Blue Water BWVI

$28K

Frequently Asked Questions

Is Quest Patent profitable?

Yes, Quest Patent (QPRC) reported a net income of $8.5M in fiscal year 2026.

What is Quest Patent's operating cash flow?

Quest Patent (QPRC) generated -$5.9M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

What are Quest Patent's total assets?

Quest Patent (QPRC) had $10.4M in total assets as of fiscal year 2026, including both current and long-term assets.

How many shares does Quest Patent have outstanding?

Quest Patent (QPRC) had 5M shares outstanding as of fiscal year 2026.

What is Quest Patent's current ratio?

Quest Patent (QPRC) had a current ratio of 0.01 as of fiscal year 2026, which is below 1.0, which may suggest potential liquidity concerns.

What is Quest Patent's debt-to-equity ratio?

Quest Patent (QPRC) had a debt-to-equity ratio of -1.61 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Quest Patent's return on assets (ROA)?

Quest Patent (QPRC) had a return on assets of 81.4% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

What is Quest Patent's cash runway?

Based on fiscal year 2026 data, Quest Patent (QPRC) had $193K in cash against an annual operating cash burn of $5.9M. This gives an estimated cash runway of approximately 0 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Why is Quest Patent's debt-to-equity ratio negative or unusual?

Quest Patent (QPRC) has negative shareholder equity of -$17.2M as of fiscal year 2026, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is Quest Patent's Piotroski F-Score?

Quest Patent (QPRC) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Quest Patent's earnings high quality?

Quest Patent (QPRC) has an earnings quality ratio of -0.70x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Quest Patent cover its interest payments?

Quest Patent (QPRC) has an interest coverage ratio of -11.0x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Quest Patent?

Quest Patent (QPRC) scores 0 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.